Medically assisted treatment for opiate addiction--suboxone method as prevention of social exclusion of youth--Tuzla model.
نویسندگان
چکیده
AIM To present medically assisted treatment for opiate addiction with substitution medicament Suboxone and prevention of social exclusion of young opiate addicts in Bosnia and Herzegovina. GENERAL OVERVIEW Until recently there was no solution for long-term and comprehensive treatment of young persons who suffer from opiate addiction. This is not an illness that impairs only psychological and physical health of addicts with possible fatal aftermaths, but serious societal problem due to its consequences such as delinquency, crimes and violence that lead young people to social exclusion. There are no capacities within the existing health facilities for long-term stationary treatment, which is necessary for drug addiction. In addition, far less adequate solution is placement of young addicts into penal and correctional institutions, which are stigmatizing and contribute to their exclusion from normal social life. Hence, the latest medically assisted method of substitution treatment with a combination of buprenorphine and naloxone (Suboxone) is introduced. This medicament, with its characteristics, offers possibility for outpatient treatment, and prompt and effective results of detoxification and weaning of opiates is to be achieved. Opiate addicts that undergo this treatment benefit from "clear mind" and capability for occupational and social activities, which significantly improves the quality of their family and social relations. With Suboxone substitution method, the institutional (inpatient) treatment is to be avoided and social exclusion of young addicts treated with Suboxone prevented. CONCLUSION Medically assisted treatment for opiate addiction with Suboxone is conducted in outpatient setting with the involvement of close relatives who are not addicted. It brings back "clear mind" to previous addicts, does not stigmatize but contribute to re-socialization and prevention of social exclusion of young opiate addicts.
منابع مشابه
Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence.
Buprenorphine/naloxone (Suboxone) comprises the partial mu-opioid receptor agonist buprenorphine in combination with the opioid antagonist naloxone in a 4 : 1 ratio. When buprenorphine/naloxone is taken sublingually as prescribed, the naloxone exerts no clinically significant effect, leaving the opioid agonist effects of buprenorphine to predominate. However, when buprenorphine/naloxone is pare...
متن کاملSuboxone (buprenorphine/naloxone) as an agonist opioid treatment in Spain: a budgetary impact analysis.
OBJECTIVE To evaluate the economic impact of buprenorphine/naloxone (B/N) as an agonist opioid treatment for opiate dependence. METHODS A budgetary impact analysis model was designed to calculate the annual costs (drugs and associated costs) to the Spanish National Healthcare System of methadone versus B/N. Data for the model were obtained from official databases and expert panel opinion. R...
متن کاملPredicting biopsychosocial outcomes for heroin users
Background Opiate substitution treatment for heroin users reduces mortality, illicit drug use, crime, and risk-taking behaviour, and improves physical, mental and social functioning. Few extended studies have been carried out in UK primary care to study factors predicting recovery. Aim To establish whether primary care opiate substitution treatment is associated with improvements in outcomes ov...
متن کاملTwo-year Experience with Buprenorphine-naloxone (Suboxone) for Maintenance Treatment of Opioid Dependence Within a Private Practice Setting.
Office-based buprenorphine-naloxone (Suboxone) treatment in the United States has significantly improved access to safe and effective opioid-dependence therapy. Little data from physicians' experiences prescribing Suboxone in private offices have been available. This retrospective chart review describes a family practitioner's first 2 years of clinical experience prescribing Suboxone for opioid...
متن کاملSuperiority of Buprenorphine over Suboxone in Preventing Addiction Relapse in Opioid Addicts under Maintenance Therapy: A Double-Blind Clinical Trial
Background: In maintenance therapy for opioid addiction, to reduce the risk of buprenorphine (BUP) abuse, the combination of BUP and naloxone (NX) has been developed and is commercially available as suboxone (BUP/NX). This study was designed to compare addiction relapse frequency in patients receiving BUP and BUP/NX as maintenance therapy. Methods: In this double-blind clinical trial with cross...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Psychiatria Danubina
دوره 24 Suppl 3 شماره
صفحات -
تاریخ انتشار 2012